Biofrontera (BFRI) Free Cash Flow (2020 - 2025)
Biofrontera has reported Free Cash Flow over the past 6 years, most recently at -$2.4 million for Q4 2025.
- For Q4 2025, Free Cash Flow fell 147.08% year-over-year to -$2.4 million; the TTM value through Dec 2025 reached -$13.4 million, down 30.37%, while the annual FY2025 figure was -$13.4 million, 30.37% down from the prior year.
- Free Cash Flow for Q4 2025 was -$2.4 million at Biofrontera, up from -$3.8 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $94000.0 in Q2 2022 and troughed at -$21.0 million in Q4 2021.
- A 5-year average of -$4.6 million and a median of -$3.4 million in 2021 define the central range for Free Cash Flow.
- Biggest five-year swings in Free Cash Flow: skyrocketed 108.89% in 2022 and later crashed 11084.04% in 2023.
- Year by year, Free Cash Flow stood at -$21.0 million in 2021, then surged by 60.6% to -$8.3 million in 2022, then fell by 7.12% to -$8.9 million in 2023, then skyrocketed by 88.98% to -$977000.0 in 2024, then crashed by 147.08% to -$2.4 million in 2025.
- Business Quant data shows Free Cash Flow for BFRI at -$2.4 million in Q4 2025, -$3.8 million in Q3 2025, and -$3.1 million in Q2 2025.